Sun Pharmaceutical Industries Limited has acquired Organon & Co in an all‑cash deal, valuing Organon at $11.75 billion.
The acquisition will be made through Sun Pharmaceutical Holdings a U.S. subsidiary of Sun Pharma.
According to the press release, after this deal, Sun Pharma will one of the 25 largest pharma companies in the world with a $12.4 Billion revenue.
AZB & Partners is advising Sun Pharma on Indian law aspects of this acquisition.
The transaction team consisted of Vaidhyanadhan Iyer (Senior Partner), Jeet Chaudhuri (Partner), Bhanu Prakash J. (Senior Associate), Manhar Chaudhary (Senior Associate), Nishita Agrawal (Senior Associate), Priya Venkatesan (Senior Associate) and Vidhi Barot.
Nilang T. Desai (Senior Partner) and Avinash Subramanian (Partner), along with their team, advised on financing law aspects of the transaction.
White & Case LLP is serving as legal advisor to Sun Pharma.
The transaction team is led by Keith Hallam (Partner, New York) and Matt Barnett (Partner, Los Angeles).
Cyril Amarchand Mangaldas is advising Organon on Indian law aspects of the acquisition.
The transaction team is led by Ruetveij Pandya (Partner) and Saloni Shroff (Partner), with assistance from Abhilasha Malpani (Principal Associate), Associates Sajith Anjickal, Chelsea Sawlani, Neelanshi Gupta, Simran Srivastava, and Shravan Subramanian.
Rishabh Shroff (Partner, Co-Head - Private Client and Head - International Business Development) is providing strategic inputs and guidance.
Meeta Kurpad (Partner), with support from Manasvin Andra (Associate), is advising on financing aspects of the transaction.
Sullivan & Cromwell LLP is serving as legal advisor to Organon.
The transaction team consists of Alison Ressler (Senior Partner), Scott Crofton (Partner), Associates Nickolas Kinslow, Matthew Ybarra, Jan Lukas Werner, Logan Seymour and Henri Adams.
Ari Blaut (Partner), Chris McLaughlin (Partner), Associates Michael Poolton and Theodore Batis are advising on financing matters.
Renata Hesse (Partner), Michael Rosenthal (Partner), Eric Kadel (Partner), Manon Scales (Special Counsel), Lori Sherman (Special Counsel), Associates Kolja Ortmann, Justin Gibbs, Penelope Bergkamp and Giovanna Intrieri are advising on regulatory matters.
Regina Readling (Partner) and Rebecca Rabinowitz (Associate) are advising on executive compensation matters.
Davis Wang (Partner), Associates Stephen Profeta and Zachary Hayworth are advising on tax matters.
Rachel Yu (Partner), Associates Elizabeth Cheung and Kelvin Kim are advising on intellectual property matters.
Matthew Brennan (Special Counsel) is advising on environmental matters.
TT&A advised Citigroup Global Markets Asia Ltd., JPMorgan Chase Bank, N.A. and MUFG Bank, Ltd., who are serving as financing banks for Sun Pharma for the purpose of this acquisition.
The transaction team consisted of Sonali Mahapatra (Partner), Nidhi Rani (Partner) and Rohan Mitra (Senior Associate).
Linklaters served as the international legal counsel to the financing banks.
The transaction team consisted of Banking Partners Phil Badge and Rahul Chatterji, and Amit Singh (Head of India Practice).
US-based Organon & Co. a global healthcare company, with diverse portfolio across women’s health, biosimilars, and therapies and products for a wide range of conditions and diseases.
Headquartered in India, Sun Pharma is the fourth largest specialty generic pharmaceutical company worldwide. Sun Pharma operates in more than 100 countries and has a global revenue of around US$ 6.2 billion. The company is supported by 41 manufacturing facilities and is known for providing high-quality, affordable medicines across various therapeutic areas.
If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.